TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS

The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AKSIONOV HENNADII MYKOLAIOVYCH, SOBETSKY VOLODYMYR VITALIIOVYCH
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture followed by treating the suitable carrier. The amount of the carrier is calculated accounting for alkaloid content of 0.0125-0.0375 mg per one tablet. The carrier containing aconite alkaloids is dried and granulated. The granules are then coated with the suitable lubricant and compressed. Then method for treating cancer patients provides for prescribing 0.5-2 tablets.